The first approval of a gene therapy in the EU has been followed swiftly by news that a Celgene drug could be approved ... to patients in need,” said Jay Backstrom, Celgene’s chief medical ...

“There remains a high unmet medical need for patients with MDS or beta-thalassemia who suffer from the effects of their disease-related anemia,” said Jay Backstrom, Celgene’s chief medical ...